SCHEMBL6948290

SCHEMBL6948290

CCS[C@@H]1O[C@@H]2COC(c3ccccc3)O[C@H]2[C@H](OC)[C@H]1OC

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.59
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 1/20 0.41
ADRA1A P35348 1/20 0.34
MAPT P10636 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
SELP P16109 1/20 0.32
TSHR P16473 1/20 0.31
LMNA P02545 1/20 0.31
ATM Q13315 1/20 0.31
PDCD1 Q15116 1/20 0.30
CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17550996 0.91 L3MBTL1 (0.53) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL17550989 0.91 L3MBTL1 (0.53) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL17550987 0.91 L3MBTL1 (0.53) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL13205072 0.91 L3MBTL1 (0.57) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL14449231 0.91 L3MBTL1 (0.57) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL6951799 0.90 L3MBTL1 (0.52) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL6952628 0.90 L3MBTL1 (0.68) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL13024785 0.88 L3MBTL1 (0.52) L3MBTL1KMT2AMEN1ALDH1A1SELP
SCHEMBL10073953 0.86 L3MBTL1 (0.47) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A
SCHEMBL17636518 0.86 L3MBTL1 (0.47) L3MBTL1KMT2AMEN1ALDH1A1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534481-B1 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin SANOFI-SYNTHELABO (FR) 2003-03-18 US disclosed
EP-0912613-B1 SYNTHETIC POLYSACCHARIDES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI SYNTHELABO (FR) 2002-09-25 EP disclosed